$1.41
0.01 (+0.71%)
Labopharm, Inc. (DDSS)
CAPS Rating:
An international, specialty pharmaceutical company focused on improving existing drugs by incorporating its proprietary, advanced controlled-release technologies.

RSS Headlines
Fool UK